Cannabis Investment
The scientific field of Cannabis-based Medicines and its known benefits for patients are evolving rapidly. Worldwide, there are hundreds of ongoing clinical trials to evaluate the effects of Cannabis-based Medicines. Our network of partners combines decades of experience in the pharmaceutical sector, with technical expertise and knowledge across the whole value chain – from production and manufacturing to distribution to other wholesalers and pharmacies, as well as research.
Our overarching aim is to achieve consistently high product quality, stable supply and operational excellence to serve our customers and ultimately the patients who will benefit from our products. With our partners at Dr. Reckeweg we are able to leverage three generations of experience in botanical extraction and production to provide patients with the highest quality throughout our product portfolio.
Growth is expected for a long list of businesses, such as the cultivators and packagers of the plants, dispensaries for medical and recreational marijuana, not to mention companies creating products that use cannabis byproducts called CBDs. CBDs are non-psychoactive derivatives of cannabis, which can be used for a variety of purposes. Health professionals have touted CBDs for their ability to help patients with inflammation, chronic pain, and depression.
Companies are also capitalizing on industrial uses for cannabis. This includes the production of hemp, which can be used to make fabrics and textiles, as well as its use as additives to health food and body care products.